Type 2 Diabetes Mellitus Completed Phase Trials for Pioglitazone (DB01132)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus,Type 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01135394Pharmacogenomics of ThiazolidinedionesBasic Science
NCT00855010Pioglitazone on Pancreatic Steatosis and Bone HealthTreatment
NCT00364988Pioglitazone and Losartan Provides Additional RenoprotectionTreatment
NCT00639457Exercise and Pioglitazone for HIV-Metabolic SyndromesTreatment
NCT02098733Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus
NCT02098746Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone
NCT02068508Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"
NCT02002975Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
NCT01990300Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
NCT02181842Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>
NCT00232583Preservation of Beta-cell Function in Type 2 Diabetes MellitusTreatment
NCT00179400Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication PioglitazoneTreatment
NCT00722631Anti-Inflammatory Effects of PioglitazoneTreatment
NCT01570660Phielix et al.: Hepatic Fat Content and AdipokinesBasic Science
NCT01593371Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes PatientsBasic Science
NCT01963663Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes PatientsBasic Science
NCT02003014Pioglitazone Tablets Special Drug Use Surveillance Combined Use of Biguanides / Long-term Treatment
NCT02027103Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes PatientsBasic Science
NCT02024971Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus
NCT02133118Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.
NCT02456428Incretin-based Drugs and the Risk of Heart Failure
NCT01147627Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsTreatment
NCT00308373Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes MellitusTreatment
NCT02475499Incretin-based Drugs and Pancreatic Cancer
NCT02476760Incretin-based Drugs and Acute Pancreatitis